Elite Pharmaceuticals Inc /NV/ SEC filings ELTP
Elite Pharmaceuticals Inc /NV/ has 1,000 filings in SEC EDGAR's recent list, going back to Apr 5, 2005. Its latest annual report, Form 10-K, was filed on Jun 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Apr 14, 2026 | — |
| CORRESP | Letter to the SEC | Mar 18, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 28, 2024 | — |
| CORRESP | Letter to the SEC | Feb 20, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 22, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2021 | — |
| CORRESP | Letter to the SEC | Feb 22, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2021 | — |
| EFFECT | Filing | Jul 27, 2020 | — |
| CORRESP | Letter to the SEC | Jul 23, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2020 | — |
| D | Filing | Jul 13, 2020 | — |
| NT 10-K | Notification of late filing | Jun 14, 2019 | Mar 31, 2019 |
| CT ORDER | Filing | Sep 6, 2018 | — |
| CT ORDER | Filing | Jul 19, 2018 | — |
| CT ORDER | Filing | Oct 11, 2017 | — |
| CT ORDER | Filing | Jul 12, 2017 | — |
| EFFECT | Filing | Jun 5, 2017 | — |
| CORRESP | Letter to the SEC | Jun 2, 2017 | — |
| UPLOAD | Letter from the SEC | May 23, 2017 | — |
| D | Filing | May 10, 2017 | — |
| CT ORDER | Filing | Dec 22, 2016 | — |
| EFFECT | Filing | Jul 13, 2016 | — |
| CORRESP | Letter to the SEC | Jul 11, 2016 | — |
| CT ORDER | Filing | Jul 11, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2016 | — |
| NT 10-K | Form 12b-25 | Jun 15, 2016 | Mar 31, 2016 |
| UPLOAD | Letter from the SEC | Apr 8, 2016 | — |
| CORRESP | Letter to the SEC | Mar 18, 2016 | — |
| CORRESP | Letter to the SEC | Feb 17, 2016 | — |
| CORRESP | Letter to the SEC | Feb 4, 2016 | — |
| UPLOAD | Letter from the SEC | Jan 21, 2016 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2016 | — |
| CORRESP | Letter to the SEC | Dec 22, 2015 | — |
| CORRESP | Letter to the SEC | Dec 21, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2015 | — |
| CORRESP | Letter to the SEC | Dec 4, 2015 | — |
| UPLOAD | Letter from the SEC | Nov 23, 2015 | — |
| CORRESP | Letter to the SEC | Oct 26, 2015 | — |
| CORRESP | Letter to the SEC | Oct 7, 2015 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2015 | — |
| CT ORDER | Filing | Apr 7, 2015 | — |
| EFFECT | Filing | Jul 8, 2014 | — |
| EFFECT | Filing | May 1, 2014 | — |
| CORRESP | Letter to the SEC | Apr 28, 2014 | — |
| CORRESP | Letter to the SEC | Apr 28, 2014 | — |
| CT ORDER | Filing | Apr 28, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2014 | — |
| D | Filing | Apr 15, 2014 | — |
| 8-A12G | Filing | Nov 15, 2013 | — |
| CT ORDER | Filing | Sep 16, 2013 | — |
| EFFECT | Filing | Jun 27, 2013 | — |
| EFFECT | Filing | May 9, 2013 | — |
| D | Filing | Apr 23, 2013 | — |
| CT ORDER | Filing | Mar 12, 2013 | — |
| CT ORDER | Filing | Sep 17, 2012 | — |
| RW | Filing | Jun 20, 2012 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2012 | — |
| CORRESP | Letter to the SEC | Jan 31, 2012 | — |
| UPLOAD | Letter from the SEC | Jan 20, 2012 | — |
| CT ORDER | Filing | Nov 29, 2011 | — |
| CT ORDER | Filing | Sep 22, 2011 | — |
| CT ORDER | Filing | Aug 31, 2011 | — |
| CT ORDER | Filing | May 2, 2011 | — |
| NT 10-K | Filing | Jun 30, 2010 | Mar 31, 2010 |
| NT 10-Q | Filing | Aug 17, 2009 | Jun 30, 2009 |
| D | Filing | Jun 12, 2009 | — |
| 25 | Filing | May 11, 2009 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2009 | — |
| CORRESP | Letter to the SEC | Apr 14, 2009 | — |
| CORRESP | Letter to the SEC | Apr 14, 2009 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2009 | — |
| CORRESP | Letter to the SEC | Mar 12, 2009 | — |
| CORRESP | Letter to the SEC | Mar 12, 2009 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2009 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2008 | — |
| PRER14A | Filing | Nov 20, 2008 | — |
| UPLOAD | Letter from the SEC | Nov 17, 2008 | — |
| PRER14A | Filing | Nov 7, 2008 | — |
| UPLOAD | Letter from the SEC | May 21, 2008 | — |
| PRER14A | Filing | May 21, 2008 | — |
| UPLOAD | Letter from the SEC | May 20, 2008 | — |
| UPLOAD | Letter from the SEC | May 2, 2008 | — |
| PRER14A | Filing | May 2, 2008 | — |
| UPLOAD | Letter from the SEC | May 1, 2008 | — |
| EFFECT | Filing | Jan 25, 2008 | — |
| CORRESP | Letter to the SEC | Jan 24, 2008 | — |
| CORRESP | Letter to the SEC | Jan 14, 2008 | — |
| UPLOAD | Letter from the SEC | Jan 10, 2008 | — |
| CORRESP | Letter to the SEC | Jan 7, 2008 | — |
| CORRESP | Letter to the SEC | Jan 4, 2008 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2007 | — |
| EFFECT | Filing | Jul 10, 2007 | — |
| EFFECT | Filing | Jul 10, 2007 | — |
| REGDEX | Auto-generated paper document | Mar 24, 2006 | — |
| RW | Filing | Mar 1, 2006 | — |
| RW | Filing | Mar 1, 2006 | — |
Showing 98 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELTP (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NJ
- Headquarters
- Northvale, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1053369
- Former names
- ELITE PHARMACEUTICALS INC /DE/ (until Feb 8, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.